Hosein I N, de Freitas R, Beaubrun M H
Curr Med Res Opin. 1978;5(8):632-6. doi: 10.1185/03007997809110199.
An open study was carried out in 21 chronic alcoholics with severe withdrawal symptoms and incipient delirium tremens to evaluate the efficacy of adjuvant treatment with intramuscular lorazepam (5mg). All symptoms subsided within 2 hours after a single injection and remained under control with oral lorazepam (mean daily dose 7 mg). No adverse reactions attributable to lorazepam were observed.
对21名有严重戒断症状和早期震颤谵妄的慢性酗酒者进行了一项开放性研究，以评估肌肉注射劳拉西泮（5毫克）辅助治疗的效果。单次注射后2小时内所有症状均消失，口服劳拉西泮（平均每日剂量7毫克）后症状得到控制。未观察到与劳拉西泮相关的不良反应。
